A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel® with CPG 7909, using two different formulations and dosing intervals

✍ Scribed by Ruth D. Ellis; Gregory E.D. Mullen; Mark Pierce; Laura B. Martin; Kazutoyo Miura; Michael P. Fay; Carole A. Long; Donna Shaffer; Allan Saul; Louis H. Miller; Anna P. Durbin

• Book ID: 116961611
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 324 KB
• Volume: 27
• Category: Article
• ISSN: 0264-410X
• DOI: 10.1016/j.vaccine.2009.04.077